MOLLY NICASTRO: Open Payments
NPI 1639689540 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 8 payments from 6 companies in 2025. Trend: 2023 $749 · 2024 $590 · 2025 $165
Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $28 |
| Novo Nordisk Inc | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: UBRELVY, Veozah, AREXVY, VRAYLAR, PREVNAR 20, XIFAXAN, SHINGRIX.
Industry payments across PA — which companies pay providers there.
